Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-03-28Individually Randomised, Placebo-controlled, Parallel Arm RCT With 12-month Follow-up to Establish the Clinical and Cost Effectiveness of the Antidepressant Citalopram in the Management of Negative Symptoms of Schizophrenia
-
CLINICAL_TRIALS study record update · 2024-03-27Network Mediation of Experiential and Expressive Deficits in Psychotic Disorders
-
CLINICAL_TRIALS study record update · 2024-03-25Treatment of Auditory Hallucinations in Schizophrenia With Bilateral Theta Burst Stimulation
-
CLINICAL_TRIALS study record update · 2024-03-22Predictive Models of Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment
-
CLINICAL_TRIALS study record update · 2024-03-20Combining Clemastine and Aerobic Exercise to Treat Cognitive Dysfunction in Schizophrenia by Targeting Myelin Plasticity
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-03-19A Randomized, Single-Dose, Open-Label, Parallel-Group Study to Evaluate the Pharmacokinetic Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
-
CLINICAL_TRIALS study record update · 2024-03-18Music Therapy to Reduce Anxiety in Community-Dwelling Individuals With Severe Mental Illness
-
CLINICAL_TRIALS study record update · 2024-03-15"Assessment and Treatment of Communicative Pragmatic Abilities in Neurological and Psychiatric Disorders: Feasibility and Clinical Efficacy (PATHS)"
-
CLINICAL_TRIALS study record update · 2024-03-15A Randomized, Double-blind, Parallel-group, Placebo Controlled, Fixed-dose, Multicenter Study to Evaluate the Efficacy and Safety of SEP 363856 in Acutely Psychotic Patients With Schizophrenia, Followed by an Open-label Extension Phase
-
CLINICAL_TRIALS study record update · 2024-03-12Investigating the Efficacy of Hippotherapy Program on Disease Symptoms, Quality of Life, Anxiety and Loneliness Levels in Patients With Schizophrenia: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2024-03-08Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 409306 Film-coated Tablets Given Orally q.d. for 14 Days in Patients With Schizophrenia (Randomized, Parallel-group, Double-blind, Placebo-controlled Study)
-
CLINICAL_TRIALS study record update · 2024-03-08Dietary Intervention for Psychotic Disorders: a Pilot Intervention Study of Ketogenic Diet for Psychotic Symptoms - PsyDiet Pilot Study
-
CLINICAL_TRIALS study record update · 2024-03-08Dance/Movement Therapy for Improving Bone Mineral Density in Long-term Patients With Schizophrenia: a Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2024-03-08The Role of Inflammation in Brain and Cognitive Function in Mental Disorders
-
CLINICAL_TRIALS study record update · 2024-03-08A Multicenter, Randomized, Placebo-Controlled, Double-Blinded Phase Ⅰ Study to Evaluate the Tolerability and Pharmacokinetics of HS-10509 in Chinese Adult Subjects
-
CLINICAL_TRIALS study record update · 2024-02-28A Phase 2, 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics of 3 Dose Levels of TAK-831 in Adjunctive Treatment of Adult Subjects With Negative Symptoms of Schizophrenia
-
CLINICAL_TRIALS study record update · 2024-02-28A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate Pharmacodynamic Effects, Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of TAK-831 in Adult Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2024-02-26Validation of the Lithuanian Version of the Brief Negative Symptoms Scale, Calgary Depression Scale for Schizophrenia, and the Schizophrenia Cognition Rating Scale
-
CLINICAL_TRIALS study record update · 2024-02-23Psychological Interventions for Complex PTSD And Schizophrenia-Spectrum Disorder: PICASSO Trial
-
CLINICAL_TRIALS study record update · 2024-02-23Effects of Transcranial Direct Current Stimulation on Stress Reactivity and Decision Making in Unaffected Siblings of Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2024-02-16Developing and Testing of Integrating Self-Determination Theory and Motivational Interviewing Based Diabetic Self-management Program Among Schizophrenic Patients With Diabetes
-
CLINICAL_TRIALS study record update · 2024-02-16Efficacy of tDCS in the Treatment of Resistant Auditory Hallucinations in Schizophrenia: A Double Blind, Randomized Controlled Study
-
CLINICAL_TRIALS study record update · 2024-02-16Impact of tDCS on Cannabis Craving in Patients With Schizophrenia and Cannabis Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study
-
CLINICAL_TRIALS study record update · 2024-02-15Structural and Functional Correlates of Clinical Response to Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment in Schizophrenia Patients With Resistant Auditory Hallucinations
-
CLINICAL_TRIALS study record update · 2024-02-14Cannabis and Thought Disorder in Schizophrenia: Clinical and Neuroimaging Relationships